CordenPharma has announced the executive appointments of Dr. Riku Heikki Rautsola as the new chief executive officer & president, Dr. Walter Kittl as its new chief operating officer, and as of May 2018, Heiko Serwe as its new chief financial officer.  

Dr. Riku Rautsola has over 30 years experience in life science companies. His prior experience consists of high level executive and supervisory board level positions within large global companies as well as within medium and small-sized innovative corporations. On several occasions Riku has been an interim executive for CordenPharma, initiating significant and valuable progress for the group. 

Dr. Walter Kittl has over 35 years of experience in the pharmaceutical, CMO, and fine chemical industries. Water most recently was at Siegfried AG, where he was President & General Manager of Siegfried USA before becoming the Head of Global Technical Operations with oversight over all drug substance and drug product sites. 

Heiko Serwe will join CordenPharma from the industrial holding company Adcuram Group, where he was Director of Finance and Controlling for a number of portfolio companies. Prior to that Heiko held various positions of increasing responsibility at Gerresheimer, culminating as Head of Finance and Controlling. 

Managing Directors Dr. Achim Riemann and Patrick Schnitzer of CordenPharma’s parent company International Chemical Investors Group (ICIG) say that they are pleased with the appointments, and are confident the leadership, business acumen, and track record of this new executive team will bring vision and growth to realize the full potential of CordenPharma in the years to come.